Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ: OCGN )

0.5425 -0.0342 (-5.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
33 34 Next >
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
Select analysts expect these small-caps stocks to catapult higher in the new year. 
Via The Motley Fool
7 ‘Loser’ Stocks to Short for Big Profits
These stocks to short can generate significant profits for investors, as they are all tremendously overvalued at this point. 
Via InvestorPlace
Exclusive: Top 10 Most Searched Tickers On Benzinga Pro In 2022 — Where Do SPY, Tesla, Apple And AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a leading source for traders to see the latest news on the overall market and individual tickers all in one... 
Via Benzinga
Why Is Party City (PRTY) Stock Up 41% Today?
Party City (PRTY) stock is in the news Monday as investors prepare for the celebration goods company to file for bankruptcy. 
Via InvestorPlace
Ocugen Announces Encouraging Data From Late-Stage COVID-19 Vaccine Study
Via Benzinga
Why Shares of Ocugen Jumped Thursday
Could short-sellers be enacting a squeeze? 
Via The Motley Fool
Why Is Ocugen (OCGN) Stock Up Today?
Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines. 
Via InvestorPlace
Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories
Bloomberg 
Via Benzinga
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met
From Ocugen
Via GlobeNewswire
Why Ocugen Stock Wilted on Wednesday
A prognosticator got less bullish on the company's prospects, and investors took this to heart. 
Via The Motley Fool
Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript
OCGN earnings call for the period ending September 30, 2022. 
Via The Motley Fool
7 Hot Meme Stocks of 2022 to Sell Before 2023
The value of most of the meme stocks have plunged, but there are still many meme stocks to sell at this point. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
Why Is Agrify (AGFY) Stock Down 50% Today?
Agrify (AGFY) stock is on the move Friday as the company's shares take a beating after revealing details of a stock offering. 
Via InvestorPlace
OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial
OCGN stock fell into the red despite Ocugen's success in advancing a regenerative cell therapy product evaluation. 
Via InvestorPlace
Ocugen Announces Phase 3 Confirmatory Clinical Trial Agreement for NeoCart®
Important next step for Ocugen’s regenerative cell therapy in orthopedics since announcing pipeline expansion in May 2022 
From Ocugen
Via GlobeNewswire
Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell
From Ocugen
Via GlobeNewswire
7 Tech Stocks to Sell Before They Topple in 2023
It's much harder now than in 2021 to find tech stocks to sell, but some tech names are still dramatically overvalued. 
Via InvestorPlace
Ocugen Announces Update on OCU400 Phase 1/2 Clinical Trial Targeting Retinitis Pigmentosa and Leber Congenital Amaurosis
From Ocugen
Via GlobeNewswire
Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit
From Ocugen
Via GlobeNewswire
3 Stocks to Avoid Right Now
Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective. 
Via The Motley Fool
Why Ocugen Stock Popped by 7% on Tuesday
A third-quarter report, complete with clinical updates, is more than enough to satisfy the biotech's bulls. 
Via The Motley Fool
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
From Ocugen
Via GlobeNewswire
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Gainers 
Via Benzinga
3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall Street
Select analysts and pundits foresee game-changing upside from this fast-paced trio. 
Via The Motley Fool
Warning! Don’t Even Consider Buying These 7 Dead-Money Stocks
These dead-money stocks exhibit incredible volatility and present themselves as remarkably risky bets in this current economic environment. 
Via InvestorPlace
Ocugen to Host Conference Call on Tuesday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2022 Financial Results
From Ocugen
Via GlobeNewswire
Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022
From Ocugen
Via GlobeNewswire
What Happened With Ocugen Shares During Wednesday's After-Hours Session
Ocugen Inc (NASDAQ: OCGN) shares traded marginally higher by 1.22% at $1.66 during Wednesday's after-hours session. 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.